These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2. Chuntharapai A, Gibbs V, Lu J, Ow A, Marsters S, Ashkenazi A, De Vos A, Jin Kim K. J Immunol; 1999 Jul 15; 163(2):766-73. PubMed ID: 10395669 [Abstract] [Full Text] [Related]
4. Evidence for glycosphingolipid modification of the type 1 IFN receptor. Ghislain J, Lingwood CA, Fish EN. J Immunol; 1994 Oct 15; 153(8):3655-63. PubMed ID: 7930586 [Abstract] [Full Text] [Related]
10. Structure-function analysis of human IFN-alpha. Mapping of a conformational epitope by homologue scanning. Wang L, Hertzog PJ, Galanis M, Overall ML, Waine GJ, Linnane AW. J Immunol; 1994 Jan 15; 152(2):705-15. PubMed ID: 7506733 [Abstract] [Full Text] [Related]
14. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. Navenot JM, Wang ZX, Trent JO, Murray JL, Hu QX, DeLeeuw L, Moore PS, Chang Y, Peiper SC. J Mol Biol; 2001 Nov 09; 313(5):1181-93. PubMed ID: 11700073 [Abstract] [Full Text] [Related]